Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
501. |
ECCT/25/01/03 | FETAL LITE STUDY Evaluation of Fetal Lite Device for Reducing Perinatal Mortality through Enhanced Labor Monitoring in Low-Resource Settings: A Pilot Study at Kenyatta National Hospital |
Principal Investigator(s) 1. GEORGE GWAKO 2. Alfred Osoti 3. Rosa Chemwey Site(s) in Kenya Kenyatta National Hospital |
13-05-2025 |
View |
502. |
ECCT/25/02/01 | IMPAACT 2037 Open-Label, Phase I Study of the Safety and Pharmacokinetics of PGT121.414.LS alone and in combination with VRC07-523LS in Infants Exposed to HIV-1 |
Principal Investigator(s) 1. Lucy C. Koech Site(s) in Kenya Kenya Medical Research Institute/Walter Reed Project |
18-12-2025 |
View |
503. |
ECCT/25/02/02 | HPV vaccine feasibility study Generating local data on HPV vaccination impact and training needs at the level of vaccine implementers – A feasibility study |
Principal Investigator(s) 1. Prof Kenneth Ngure Site(s) in Kenya KEMRI-CCR PHRD( (THIKA) PROJECT |
29-04-2025 |
View |
504. |
ECCT/25/02/03 | NOZE20240219TB “Validation of a Digital Olfaction Based Breathalyzer Device for Non-Invasive Detection of Volatile Biomarkers in Patients with and without Tuberculosis: Case Control Study”. |
Principal Investigator(s) 1. Ibrahim Daud Site(s) in Kenya KEMRI/WRP CRC Kericho |
15-05-2025 |
View |
505. |
ECCT/25/02/04 | Clearance of High-Risk HPV A Randomized, Placebo-Controlled Study to Evaluate Clearance of High-Risk Human Papillomavirus and Safety After Administration of ABI-2280 Vaginal Inserts |
Principal Investigator(s) 1. Jacqueline Mirera Site(s) in Kenya 1. CREA-N Machakos Level 5 Hospital Site (Machakos county) |
06-03-2025 |
View |
506. |
ECCT/25/02/05 | Clearance of High-Risk HPV A Randomized, Placebo-Controlled Study to Evaluate Clearance of High-Risk Human Papillomavirus and Safety After Administration of ABI-2280 Vaginal Inserts |
Principal Investigator(s) 1. Irene Diana Odhiambo Site(s) in Kenya 1. Victoria Biomedical Research Institute, Kisumu County Referral Hospital (Kisumu county) |
07-03-2025 |
View |
507. |
ECCT/25/02/06 | Clearance of High-Risk HPV A Randomized, Placebo-Controlled Study to Evaluate Clearance of High-Risk Human Papillomavirus and Safety After Administration of ABI-2280 Vaginal Inserts |
Principal Investigator(s) 1. Omu Anzala Site(s) in Kenya 1. KAVI-Institute of Clinical Research (KAVI - ICR) (Nairobi City county) |
06-03-2025 |
View |
508. |
ECCT/25/02/07 | Clearance of High-Risk HPV A Randomized, Placebo-Controlled Study to Evaluate Clearance of High-Risk Human Papillomavirus and Safety After Administration of ABI-2280 Vaginal Inserts |
Principal Investigator(s) 1. Elizabeth Anne Bukusi Site(s) in Kenya 1. KEMRI-RCTP (Kisumu county) |
13-03-2025 |
View |
509. |
ECCT/25/02/08 | Clearance of High-Risk HPV A Randomized, Placebo-Controlled Study to Evaluate Clearance of High-Risk Human Papillomavirus and Safety After Administration of ABI-2280 Vaginal Inserts |
Principal Investigator(s) 1. Valentine Chepkorir Sing’oei Site(s) in Kenya 1. KEMRI –USAMRD-A, Kombewa Clinical Research Centre (Kisumu county) |
06-03-2025 |
View |
510. |
ECCT/25/02/09 | DASH II Study Diagnostic Access to Self-Care & Health Services in Low- and Middle-Income Countries (DASH) – Phase II Study |
Principal Investigator(s) 1. ELIZABETH ANNE BUKUSI Site(s) in Kenya Migori County |
23-05-2025 |
View |